Healthy Skepticism Library item: 5248

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Ragg M.
MaLAM and Augmentin
Lancet 1993; 342:487

Abstract:

The Medical Lobby for Appropriate Marketing has written to SmithKline Beecham to ask for justification for its claims about Augmentin in Australia and Bangladesh.

Keywords:
*news story/Australia/Bangladesh/Medical Lobby for Appropriate Marketing/MaLAM/Augmentin/SmithKline Beecham/quality of information/developing countries/quality of information/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES